• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Mass Spectrometry-Toxicology
Mass Spectrometry-Toxicology

... sort and detect compounds by their mass/charge ratio. We test urine, whole blood, serum and saliva. We are unique in that we do not run FDA developed testing but develop and validate our own LCMS methods. Our lab has the most mass specs in a clinical lab setting in the region. Currently we have 6 LC ...
HYPERTENSION
HYPERTENSION

... calcium antagonists, ACE inhibitors and αblockers) have shown no consistent or important differences in outcome, efficacy, side-effects or quality of life . The choice of antihypertensive therapy is therefore usually dictated by cost, convenience, the response to treatment and freedom from side-effe ...
Twitter feed suggestions 2012 Annual report (140)
Twitter feed suggestions 2012 Annual report (140)

... were reported in Europe in 2011. While this is down on the 7 700 cases reported in 2009, reducing drug-related deaths remains a major challenge for public health policy in Europe, with rising death tolls reported in some countries. This POD looks at the variety of factors that increase the risk of f ...
Drugs - Wando High School
Drugs - Wando High School

... dependence  caused by repeated usage that changes body chemistry  Psychological dependence  a pattern of habitual or compulsive use of a drug in order to satisfy a psychological need ...
Drugs and Drug Abuse
Drugs and Drug Abuse

... Copyright © Allyn & Bacon 2007 ...
NEWS YOU CAN USE 2015 03 UPD
NEWS YOU CAN USE 2015 03 UPD

... successfully completed its Phase 2 trial for once-daily oral semaglutide vs onceweekly subcutaneously administered semaglutide (in Phase 3) • This would be the first oral GLP-1 receptor ...
Ch 4 Drug Effects on the Brain
Ch 4 Drug Effects on the Brain

... Drugs interfere with neurotransmission. Drugs of abuse produce feelings of pleasure by altering neurotransmission by neurons in the reward system that release the neurotransmitter dopamine. Drugs like alcohol, heroin, and nicotine excite the dopamine-containing neurons so that they produce more acti ...
Human Immunodeficiency Virus (HIV) Acquired Immunodeficiency
Human Immunodeficiency Virus (HIV) Acquired Immunodeficiency

... A broad view of adherence: – recognizes that adherence is not only about taking one’s medications – actively engages patients in health care and treatment – values the health impacts of “non-medical” interventions, including controlled drug use, stable housing, social supports, harm reduction, and g ...
Slide 1
Slide 1

... delivery of the drug to the body under normal and pathologic conditions (impaired physiological function). ...
Противомикробни средства
Противомикробни средства

... In some infections the choice of antimicrobails follows automatically from the cliniccal diagnosis because the causative organknish is always the same, and is virtually always sensitive to the same drug, e.g. segmental pneumonia in a young person which is almost always caused by S. pneumonia (benzy ...
AJ 113: Forensic Chemistry: Drugs
AJ 113: Forensic Chemistry: Drugs

... 5 schedules of classification for controlled dangerous substances on the basis of a drug’s potential for abuse, potential fo physical and psychological dependence and medical value Flexible: as the US attorney general has the authority to add, delete, or reschedule a drug as more information becomes ...
THE SAFETY PHARMACOTHERAPY DURING PREGNANCY
THE SAFETY PHARMACOTHERAPY DURING PREGNANCY

... controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the first trimester (and there is no evidence of a risk in later trimesters). Example: penicillins C- Either ...
Stop Drugging Our Elders!
Stop Drugging Our Elders!

...  AMDA: I do not prescribe antipsychotic drugs for treatment of agitation or other behaviors in patients with dementia. ...
1097-Ahmadi-_b
1097-Ahmadi-_b

... have multiple medical problems, requiring prescription drugs to treat diseases and to prevent the arising complications. • Moreover complex medical conditions are frequent and often involve multiple drug therapy. • The elderly people consume about four times as many daily doses as the rest of the po ...
Not For Human Consumption - North Inner City Drugs Task Force
Not For Human Consumption - North Inner City Drugs Task Force

... ‘Incense’ or ‘Plant food’ or ‘Bath salts’ (which they are not), allowing them to by-pass the need for testing and pretending that they are ‘legal’ They have exploited a kind of loophole in the current law and regulations These drug products are ‘NOT LEGAL’ ...
HRP- 306 - WORKSHEET
HRP- 306 - WORKSHEET

... The purpose of this worksheet is to provide support for IRB staff pre-reviewing research involving drugs. This worksheet is to be used. It does not need to be completed or retained. ...
WORKSHEET: Drugs
WORKSHEET: Drugs

... Category #1: Lawfully Marketed Drugs (21 CFR 212.2(b)(1)) The drug is lawfully marketed in the United States. The research is not intended to be reported to the FDA as a well-controlled study in support of a new indication for use nor intended to be used to support any other significant change in th ...
chapt12_lecture
chapt12_lecture

... • Identify the microorganism causing the infection. • Test the microorganism’s susceptibility (sensitivity) to various drugs in vitro when indicated. • The overall medical condition of the patient ...
Pharm II-Ch 8-PPT
Pharm II-Ch 8-PPT

... • PEOPLE TRAVELING TO AN AREA WHERE MALARIA IS ENDEMIC • PATIENTS WHO ARE UNDERGOING GI OR GENITOURINARY SURGERY • PATIENTS WITH KNOWN CARDIAC VALVE DISEASE, VALVE REPLACEMENTS, AND OTHER CONDITIONS REQUIRING INVASIVE PROCEDURES ...
MED 266: Pharmacology Chapter 20 Worksheet Key
MED 266: Pharmacology Chapter 20 Worksheet Key

... 24. Gout is a special inflammatory disease. People who suffer from gout may overproduce ________ ________ or may not excrete it efficiently. The clinical management of gout, even with diet adjustment, is a life-long process. For the treatment of acute gout attacks, relief of pain, and interruption o ...
WORKSHEET: Drugs - UC Davis Office of Research
WORKSHEET: Drugs - UC Davis Office of Research

... submissions to FDA meet this requirement. iv If there are questions about which category is appropriate, have the investigator apply for an IND following 21 CFR §312.23. v The investigator or other designated individual must maintain records of the product's delivery to the clinical trial site, the ...
Pharmacology: The Study of Drugs
Pharmacology: The Study of Drugs

... – Chemically changed into compounds that are less effective and more water soluble – occurs primarily in the liver but also in the lungs, kidneys, GI or skin. – Conditions that alter these sites may alter the elimination of the drug ...
Questions for Term Test #2
Questions for Term Test #2

... 3. Which one of the following statements best describes drugs classified as partial receptor agonists? a. Partial agonists are prodrugs that split into full agonists in the body b. Full agonists are more potent than partial agonists c. Partial agonists have less efficacy than full agonists d. Partia ...
Baron Shopsin by Andrea Tone
Baron Shopsin by Andrea Tone

... issue of some patients developing adverse haematological effects. Meanwhile, under the socialist government of Mitterrand during the 1980s, Pharmuka and its scientists were absorbed by the industry giant Rhône-Poulenc, and the fate of Indalpine with it. In or about 1987 Rhône Poulenc abruptly pulled ...
PRESCRIBING OPIOIDS for OFFICE BASED OPIOID TREATMENT
PRESCRIBING OPIOIDS for OFFICE BASED OPIOID TREATMENT

... >80% childhood sexual abuse. SELF HARM: 40-50% of successful suicides, 40-80% of level I trauma FINANCIAL: productivity Not to mention all of the other medical complications / organ damage ...
< 1 ... 127 128 129 130 131 132 133 134 135 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report